{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:32:11Z","timestamp":1784547131747,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K19137"],"award-info":[{"award-number":["24K19137"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00774-025-01682-z","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T20:27:23Z","timestamp":1769977643000},"page":"312-324","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of serum magnesium levels\u00a0and calcimimetic use: fractures and cardiovascular events in Japanese haemodialysis patients"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2303-5401","authenticated-orcid":false,"given":"Tomohiro","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Mizobuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiryu","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Takezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Koiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"key":"1682_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","volume":"18","author":"AK Bello","year":"2022","unstructured":"Bello AK, Okpechi IG, Osman MA, Cho Y, Htay H, Jha V, Wainstein M, Johnson DW (2022) Epidemiology of haemodialysis outcomes. Nat Rev Nephrol 18:378\u2013395. https:\/\/doi.org\/10.1038\/s41581-022-00542-7","journal-title":"Nat Rev Nephrol"},{"key":"1682_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.RV22012","volume":"31","author":"H Ogata","year":"2024","unstructured":"Ogata H, Sugawara H, Yamamoto M, Ito H (2024) Phosphate and coronary artery disease in patients with chronic kidney disease. J Atheroscler Thromb 31:1\u201314. https:\/\/doi.org\/10.5551\/jat.RV22012","journal-title":"J Atheroscler Thromb"},{"key":"1682_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ki.2013.327","volume":"85","author":"Y Sakaguchi","year":"2014","unstructured":"Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y (2014) Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 85:174\u2013181. https:\/\/doi.org\/10.1038\/ki.2013.327","journal-title":"Kidney Int"},{"key":"1682_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s40620-019-00601-6","volume":"32","author":"J Xiong","year":"2019","unstructured":"Xiong J, He T, Wang M, Nie L, Zhang Y, Wang Y, Huang Y, Feng B, Zhang J, Zhao J (2019) Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. J Nephrol 32:791\u2013802. https:\/\/doi.org\/10.1007\/s40620-019-00601-6","journal-title":"J Nephrol"},{"key":"1682_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ekir.2016.12.008","volume":"2","author":"I Bressendorff","year":"2017","unstructured":"Bressendorff I, Hansen D, Schou M, Silver B, Pasch A, Bouchelouche P, Pedersen L, Rasmussen LM, Brandi L (2017) Oral magnesium supplementation in chronic kidney disease stages 3 and 4: efficacy, safety, and effect on serum calcification propensity-a prospective randomized double-blinded placebo-controlled clinical trial. Kidney Int Rep 2:380\u2013389. https:\/\/doi.org\/10.1016\/j.ekir.2016.12.008","journal-title":"Kidney Int Rep"},{"key":"1682_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/asn.2018111150","volume":"30","author":"Y Sakaguchi","year":"2019","unstructured":"Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T et al (2019) A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD. J Am Soc Nephrol 30:1073\u20131085. https:\/\/doi.org\/10.1681\/asn.2018111150","journal-title":"J Am Soc Nephrol"},{"key":"1682_CR7","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1161\/atvbaha.117.309182","volume":"37","author":"AD Ter Braake","year":"2017","unstructured":"Ter Braake AD, Shanahan CM, de Baaij JHF (2017) Magnesium counteracts vascular calcification: passive interference or active modulation? (in eng). Arterioscler Thromb Vasc Biol 37:1431\u20131445. https:\/\/doi.org\/10.1161\/atvbaha.117.309182","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1682_CR8","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3390\/ijms25021155","volume":"25","author":"SJ Zaslow","year":"2024","unstructured":"Zaslow SJ, Oliveira-Paula GH, Chen W (2024) Magnesium and vascular calcification in chronic kidney disease: current insights. Int J Mol Sci 25:1155. https:\/\/doi.org\/10.3390\/ijms25021155","journal-title":"Int J Mol Sci"},{"key":"1682_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20241-3","volume":"8","author":"AD Ter Braake","year":"2018","unstructured":"Ter Braake AD, Tinnemans PT, Shanahan CM, Hoenderop JGJ, de Baaij JHF (2018) Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. Sci Rep 8:2069. https:\/\/doi.org\/10.1038\/s41598-018-20241-3","journal-title":"Sci Rep"},{"key":"1682_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1124\/mol.109.058784","volume":"76","author":"Z Saidak","year":"2009","unstructured":"Saidak Z, Brazier M, Kamel S, Mentaverri R (2009) Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications. Mol Pharmacol 76:1131\u20131144. https:\/\/doi.org\/10.1124\/mol.109.058784","journal-title":"Mol Pharmacol"},{"key":"1682_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000185484","volume":"22","author":"G Molostvov","year":"2008","unstructured":"Molostvov G, Fletcher S, Bland R, Zehnder D (2008) Extracellular calcium-sensing receptor mediated signalling is involved in human vascular smooth muscle cell proliferation and apoptosis. Cell Physiol Biochem 22:413\u2013422. https:\/\/doi.org\/10.1159\/000185484","journal-title":"Cell Physiol Biochem"},{"key":"1682_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/hjh.0000000000001202","volume":"35","author":"I Alesutan","year":"2017","unstructured":"Alesutan I, Tuffaha R, Auer T, Feger M, Pieske B, Lang F, Voelkl J (2017) Inhibition of osteo\/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor. J Hypertens 35:523\u2013532. https:\/\/doi.org\/10.1097\/hjh.0000000000001202","journal-title":"J Hypertens"},{"key":"1682_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10654-017-0242-2","volume":"32","author":"SK Kunutsor","year":"2017","unstructured":"Kunutsor SK, Whitehouse MR, Blom AW, Laukkanen JA (2017) Low serum magnesium levels are associated with increased risk of fractures: a long-term prospective cohort study. Eur J Epidemiol 32:593\u2013603. https:\/\/doi.org\/10.1007\/s10654-017-0242-2","journal-title":"Eur J Epidemiol"},{"key":"1682_CR14","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1681\/asn.2017080849","volume":"29","author":"Y Sakaguchi","year":"2018","unstructured":"Sakaguchi Y, Hamano T, Wada A, Hoshino J, Masakane I (2018) Magnesium and risk of hip fracture among patients undergoing hemodialysis. J Am Soc Nephrol 29:991\u2013999. https:\/\/doi.org\/10.1681\/asn.2017080849","journal-title":"J Am Soc Nephrol"},{"key":"1682_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2019.108301","volume":"77","author":"MM Belluci","year":"2020","unstructured":"Belluci MM, de Molon RS, Rossa C Jr., Tetradis S, Giro G, Cerri PS, Marcantonio E Jr., Orrico SRP (2020) Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorption. J Nutr Biochem 77:108301. https:\/\/doi.org\/10.1016\/j.jnutbio.2019.108301","journal-title":"J Nutr Biochem"},{"key":"1682_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/jn\/130.2.216","volume":"130","author":"Y Toba","year":"2000","unstructured":"Toba Y, Kajita Y, Masuyama R, Takada Y, Suzuki K, Aoe S (2000) Dietary magnesium supplementation affects bone metabolism and dynamic strength of bone in ovariectomized rats. J Nutr 130:216\u2013220. https:\/\/doi.org\/10.1093\/jn\/130.2.216","journal-title":"J Nutr"},{"key":"1682_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bone.2005.04.005","volume":"37","author":"RK Rude","year":"2005","unstructured":"Rude RK, Gruber HE, Norton HJ, Wei LY, Frausto A, Kilburn J (2005) Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat. Bone 37:211\u2013219. https:\/\/doi.org\/10.1016\/j.bone.2005.04.005","journal-title":"Bone"},{"key":"1682_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1684\/mrh.2023.0518","volume":"36","author":"S Katsumata","year":"2023","unstructured":"Katsumata S, Matsuzaki H (2023) Short-term dietary magnesium deficiency downregulates the expression of bone formation-related genes in rats. Magnes Res 36:23\u201329. https:\/\/doi.org\/10.1684\/mrh.2023.0518","journal-title":"Magnes Res"},{"key":"1682_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2165\/00003495-200565020-00007","volume":"65","author":"JA Barman Balfour","year":"2005","unstructured":"Barman Balfour JA, Scott LJ (2005) Cinacalcet hydrochloride. Drugs 65:271\u2013281. https:\/\/doi.org\/10.2165\/00003495-200565020-00007","journal-title":"Drugs"},{"key":"1682_CR20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1681\/asn.2021040585","volume":"33","author":"M Schepelmann","year":"2022","unstructured":"Schepelmann M, Ranieri M, Lopez-Fernandez I, Webberley TS, Brennan SC et al (2022) Impaired mineral ion metabolism in a mouse model of targeted calcium-sensing receptor (CaSR) deletion from vascular smooth muscle cells. J Am Soc Nephrol 33:1323\u20131340. https:\/\/doi.org\/10.1681\/asn.2021040585","journal-title":"J Am Soc Nephrol"},{"key":"1682_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/ijne\/2492846","volume":"2025","author":"J Enge\u00dfer","year":"2025","unstructured":"Enge\u00dfer J, Albert PG, Scheuch M, Loth N, Stracke S (2025) The calcimimetic R568 reduces vascular smooth muscle cell calcification in vitro via ERK 1\/2 phosphorylation. Int J Nephrol 2025:2492846. https:\/\/doi.org\/10.1155\/ijne\/2492846","journal-title":"Int J Nephrol"},{"key":"1682_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/cvr\/cvaf016","volume":"121","author":"S de la Puente-Secades","year":"2025","unstructured":"de la Puente-Secades S, Mikolajetz D, Gayrard N, Hermann J, Jankowski V et al (2025) Vasoconstriction-inhibiting factor: an endogenous inhibitor of vascular calcification as a calcimimetic of calcium-sensing receptor. Cardiovasc Res 121:507\u2013521. https:\/\/doi.org\/10.1093\/cvr\/cvaf016","journal-title":"Cardiovasc Res"},{"key":"1682_CR23","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"EVOLVE Trial Investigators","year":"2012","unstructured":"Trial Investigators EVOLVE, Chertow GM, Block GA, Correa-Rotter R, Dr\u00fceke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TCH, Moe SM, Trotman ML, Wheeler DC, Parfrey PS (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482\u20132494. https:\/\/doi.org\/10.1056\/NEJMoa1205624","journal-title":"N Engl J Med"},{"key":"1682_CR24","doi-asserted-by":"publisher","first-page":"19612","DOI":"10.1038\/srep19612","volume":"6","author":"T Akizawa","year":"2016","unstructured":"Akizawa T, Kurita N, Mizobuchi M, Fukagawa M, Onishi Y, Yamaguchi T, Ellis AR, Fukuma S, Alan Brookhart M, Hasegawa T, Kurokawa K, Fukuhara S (2016) PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Sci Rep 6:19612. https:\/\/doi.org\/10.1038\/srep19612","journal-title":"Sci Rep"},{"key":"1682_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/pds.3789","volume":"24","author":"IA Gillespie","year":"2015","unstructured":"Gillespie IA, Floege J, Gioni I, Dr\u00fceke TB, de Francisco AL, Anker SD, Kubo Y, Wheeler DC, Froissart M (2015) Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of Cinacalcet use on all-cause mortality. Pharmacoepidemiol Drug Saf 24:738\u2013747. https:\/\/doi.org\/10.1002\/pds.3789","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1682_CR26","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ki.2010.167","volume":"78","author":"GA Block","year":"2010","unstructured":"Block GA, Zaun D, Smits G, Persky M, Brillhart S, Nieman K, Liu J, St Peter WL (2010) Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney Int 78:578\u2013589. https:\/\/doi.org\/10.1038\/ki.2010.167","journal-title":"Kidney Int"},{"key":"1682_CR27","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1159\/000504139","volume":"44","author":"Y Zu","year":"2019","unstructured":"Zu Y, Lu X, Song J, Yu L, Li H, Wang S (2019) Cinacalcet treatment significantly improves all-cause and cardiovascular survival in dialysis patients: results from a meta-analysis. Kidney Blood Press Res 44:1327\u20131338. https:\/\/doi.org\/10.1159\/000504139","journal-title":"Kidney Blood Press Res"},{"key":"1682_CR28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2217\/cer-2018-0015","volume":"7","author":"G Lozano-Ortega","year":"2018","unstructured":"Lozano-Ortega G, Waser N, Bensink ME, Goring S, Bennett H, Block GA, Chertow GM, Trotman ML, Cooper K, Levy AR, Belozeroff V (2018) Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis. J Comp Eff Res 7:693\u2013707. https:\/\/doi.org\/10.2217\/cer-2018-0015","journal-title":"J Comp Eff Res"},{"key":"1682_CR29","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","volume":"26","author":"P Raggi","year":"2011","unstructured":"Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Floege J, ADVANCE Study Group (2011) The ADVANCE study: a randomized study to evaluate the effects of Cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 26:1327\u20131339. https:\/\/doi.org\/10.1093\/ndt\/gfq725","journal-title":"Nephrol Dial Transplant"},{"key":"1682_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/s0140-6736(16)30508-6","volume":"388","author":"C Wanner","year":"2016","unstructured":"Wanner C, Amann K, Shoji T (2016) The heart and vascular system in dialysis. Lancet 388:276\u2013284. https:\/\/doi.org\/10.1016\/s0140-6736(16)30508-6","journal-title":"Lancet"},{"key":"1682_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/ndt\/gfaa222","volume":"37","author":"AD Ter Braake","year":"2022","unstructured":"Ter Braake AD, Vervloet MG, de Baaij JHF, Hoenderop JGJ (2022) Magnesium to prevent kidney disease-associated vascular calcification: crystal clear? Nephrol Dial Transplant 37:421\u2013429. https:\/\/doi.org\/10.1093\/ndt\/gfaa222. ((in eng))","journal-title":"Nephrol Dial Transplant"},{"key":"1682_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrendo.2015.30","volume":"11","author":"D Goltzman","year":"2015","unstructured":"Goltzman D, Hendy GN (2015) The calcium-sensing receptor in bone \u2013 mechanistic and therapeutic insights (in eng). Nat Rev Endocrinol 11:298\u2013307. https:\/\/doi.org\/10.1038\/nrendo.2015.30","journal-title":"Nat Rev Endocrinol"},{"key":"1682_CR33","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2215\/cjn.0000000000000254","volume":"18","author":"P Khairallah","year":"2023","unstructured":"Khairallah P, Cherasard J, Sung J, Agarwal S, Aponte MA, Bucovsky M, Fusaro M, Silberzweig J, Frumkin GN, El Hachem K, Schulman L, McMahon D, Allen MR, Metzger CE, Surowiec RK, Wallace J, Nickolas TL (2023) Changes in bone quality after treatment with etelcalcetide. Clin J Am Soc Nephrol 18:1456\u20131465. https:\/\/doi.org\/10.2215\/cjn.0000000000000254","journal-title":"Clin J Am Soc Nephrol"},{"key":"1682_CR34","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ki.2014.349","volume":"87","author":"GJ Behets","year":"2015","unstructured":"Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, D\u2019Haese PC (2015) Bone histomorphometry before and after long-term treatment with Cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int 87:846\u2013856. https:\/\/doi.org\/10.1038\/ki.2014.349","journal-title":"Kidney Int"},{"key":"1682_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/1744-9987.70004","volume":"29","author":"K Yoshida","year":"2025","unstructured":"Yoshida K, Saito T, Kato T, Takezaki T, Kato N, Mizobuchi M, Ogata H, Koiwa F, Honda H (2025) Phosphate binder pill burden and cardiovascular events in patients undergoing hemodialysis. Ther Apher Dial 29:333\u2013344. https:\/\/doi.org\/10.1111\/1744-9987.70004","journal-title":"Ther Apher Dial"},{"key":"1682_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0021-9150(97)00106-8","volume":"132","author":"LI Kauppila","year":"1997","unstructured":"Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW (1997) New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132:245\u2013250. https:\/\/doi.org\/10.1016\/s0021-9150(97)00106-8","journal-title":"Atherosclerosis"},{"key":"1682_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.rx.2015.03.002","volume":"58","author":"E Pariente-Rodrigo","year":"2016","unstructured":"Pariente-Rodrigo E, Sgaramella GA, Garc\u00eda-Velasco P, Hern\u00e1ndez-Hern\u00e1ndez JL, Landeras-Alvaro R, Olmos-Mart\u00ednez JM (2016) Reliability of radiologic evaluation of abdominal aortic calcification using the 24-point scale. Radiologia 58:46\u201354. https:\/\/doi.org\/10.1016\/j.rx.2015.03.002","journal-title":"Radiologia"},{"key":"1682_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bone.2017.01.025","volume":"104","author":"JT Schousboe","year":"2017","unstructured":"Schousboe JT, Lewis JR, Kiel DP (2017) Abdominal aortic calcification on dual-energy x-ray absorptiometry: methods of assessment and clinical significance. Bone 104:91\u2013100. https:\/\/doi.org\/10.1016\/j.bone.2017.01.025","journal-title":"Bone"},{"key":"1682_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00774-013-0447-8","volume":"31","author":"S Soen","year":"2013","unstructured":"Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, Gorai I, Shiraki M, Hagino H, Hosoi T, Ohta H, Yoneda T, Tomomitsu T, Japanese Society for Bone and Mineral Research and Japan Osteoporosis Society Joint Review Committee for the Revision of the Diagnostic Criteria for Primary Osteoporosis (2013) Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab 31:247\u2013257. https:\/\/doi.org\/10.1007\/s00774-013-0447-8","journal-title":"J Bone Miner Metab"},{"key":"1682_CR40","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000187476","volume":"65","author":"JD Harnett","year":"1993","unstructured":"Harnett JD, Murphy B, Collingwood P, Purchase L, Kent G, Parfrey PS (1993) The reliability and validity of echocardiographic measurement of left ventricular mass index in hemodialysis patients. Nephron 65:212\u2013214. https:\/\/doi.org\/10.1159\/000187476","journal-title":"Nephron"},{"key":"1682_CR41","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MSJ, Stewart WJ, Chamber Quantification Writing Group, American Society of Echocardiography\u2019s Guidelines and Standards Committee, European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463. https:\/\/doi.org\/10.1016\/j.echo.2005.10.005","journal-title":"J Am Soc Echocardiogr"},{"key":"1682_CR42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"Payne RB, Little AJ, Williams RB, Milner JR (1973) Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 4:643\u2013646. https:\/\/doi.org\/10.1136\/bmj.4.5893.643","journal-title":"Br Med J"},{"key":"1682_CR43","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10157-022-02270-5","volume":"26","author":"H Ogata","year":"2022","unstructured":"Ogata H, Fukagawa M, Hirakata H, Kagimura T, Akizawa T, LANDMARK Investigators and Committees (2022) Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial. Clin Exp Nephrol 26:1223\u20131232. https:\/\/doi.org\/10.1007\/s10157-022-02270-5","journal-title":"Clin Exp Nephrol"},{"key":"1682_CR44","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1001\/jama.2021.4807","volume":"325","author":"H Ogata","year":"2021","unstructured":"Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T, LANDMARK Investigators and Committees (2021) Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the LANDMARK randomized clinical trial. JAMA 325:1946\u20131954. https:\/\/doi.org\/10.1001\/jama.2021.4807","journal-title":"JAMA"},{"key":"1682_CR45","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10157-016-1310-8","volume":"21","author":"H Ogata","year":"2017","unstructured":"Ogata H, Fukagawa M, Hirakata H, Kaneda H, Kagimura T, Akizawa T, LANDMARK Study Group (2017) Design and baseline characteristics of the LANDMARK study. Clin Exp Nephrol 21:531\u2013537. https:\/\/doi.org\/10.1007\/s10157-016-1310-8","journal-title":"Clin Exp Nephrol"},{"key":"1682_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-025-02777-7","author":"T Kato","year":"2025","unstructured":"Kato T, Yoshida K, Abe M, Yamashita M, Kobayashi K, Saito T, Takezaki T, Kato N, Mizobuchi M, Koiwa F, Ogata H, Honda H (2025) PTH variability is associated with increased risk of mortality in Japanese hemodialysis patients. Clin Exp Nephrol. https:\/\/doi.org\/10.1007\/s10157-025-02777-7","journal-title":"Clin Exp Nephrol"},{"key":"1682_CR47","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1053\/j.ajkd.2015.05.024","volume":"66","author":"L Li","year":"2015","unstructured":"Li L, Streja E, Rhee CM, Mehrotra R, Soohoo M, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K (2015) Hypomagnesemia and mortality in incident hemodialysis patients. Am J Kidney Dis 66:1047\u20131055. https:\/\/doi.org\/10.1053\/j.ajkd.2015.05.024","journal-title":"Am J Kidney Dis"},{"key":"1682_CR48","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ndt\/gfr321","volume":"27","author":"F Kircelli","year":"2012","unstructured":"Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S, Asci G, Ok E, Passlick-Deetjen J (2012) Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 27:514\u2013521. https:\/\/doi.org\/10.1093\/ndt\/gfr321","journal-title":"Nephrol Dial Transplant"},{"key":"1682_CR49","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.kint.2017.04.011","volume":"92","author":"JM Diaz-Tocados","year":"2017","unstructured":"Diaz-Tocados JM, Peralta-Ramirez A, Rodr\u00edguez-Ortiz ME, Raya AI, Lopez I et al (2017) Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats. Kidney Int 92:1084\u20131099. https:\/\/doi.org\/10.1016\/j.kint.2017.04.011","journal-title":"Kidney Int"},{"key":"1682_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3892\/br.2015.473","volume":"3","author":"Y Bai","year":"2015","unstructured":"Bai Y, Zhang J, Xu J, Cui L, Zhang H, Zhang S, Feng X (2015) Magnesium prevents \u03b2-glycerophosphate-induced calcification in rat aortic vascular smooth muscle cells. Biomed Rep 3:593\u2013597. https:\/\/doi.org\/10.3892\/br.2015.473","journal-title":"Biomed Rep"},{"key":"1682_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7419524","volume":"2016","author":"L Louvet","year":"2016","unstructured":"Louvet L, Metzinger L, B\u00fcchel J, Steppan S, Massy ZA (2016) Magnesium attenuates phosphate-induced deregulation of a microRNA signature and prevents modulation of Smad1 and Osterix during the course of vascular calcification. Biomed Res Int 2016:7419524. https:\/\/doi.org\/10.1155\/2016\/7419524","journal-title":"Biomed Res Int"},{"key":"1682_CR52","doi-asserted-by":"publisher","first-page":"1406248","DOI":"10.3389\/fendo.2024.1406248","volume":"15","author":"L Liu","year":"2024","unstructured":"Liu L, Luo P, Wen P, Xu P (2024) The role of magnesium in the pathogenesis of osteoporosis. Front Endocrinol 15:1406248. https:\/\/doi.org\/10.3389\/fendo.2024.1406248","journal-title":"Front Endocrinol"},{"key":"1682_CR53","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/nu13020463","volume":"13","author":"M Barbagallo","year":"2021","unstructured":"Barbagallo M, Veronese N, Dominguez LJ (2021) Magnesium in aging, health and diseases. Nutrients 13:463. https:\/\/doi.org\/10.3390\/nu13020463","journal-title":"Nutrients"},{"key":"1682_CR54","doi-asserted-by":"publisher","first-page":"2182603","DOI":"10.1080\/0886022x.2023.2182603","volume":"45","author":"Y Zhan","year":"2023","unstructured":"Zhan Y, Zhang R, Li G (2023) Effect of magnesium on vascular calcification in chronic kidney disease patients: a systematic review and meta-analysis. Ren Fail 45:2182603. https:\/\/doi.org\/10.1080\/0886022x.2023.2182603","journal-title":"Ren Fail"},{"key":"1682_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116233","volume":"154","author":"I Groenendijk","year":"2022","unstructured":"Groenendijk I, van Delft M, Versloot P, van Loon LJC, de Groot LCPGM (2022) Impact of magnesium on bone health in older adults: a systematic review and meta-analysis. Bone 154:116233. https:\/\/doi.org\/10.1016\/j.bone.2021.116233","journal-title":"Bone"},{"key":"1682_CR56","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.jrn.2021.07.009","volume":"32","author":"G Guo","year":"2022","unstructured":"Guo G, Zhou J, Xu T, Sheng Z, Huang A, Sun L, Yao L (2022) Effect of magnesium supplementation on chronic kidney disease-mineral and bone disorder in hemodialysis patients: a meta-analysis of randomized controlled trials. J Ren Nutr 32:102\u2013111. https:\/\/doi.org\/10.1053\/j.jrn.2021.07.009","journal-title":"J Ren Nutr"},{"key":"1682_CR57","doi-asserted-by":"publisher","DOI":"10.1177\/20543581231154183","volume":"10","author":"AC Cowan","year":"2023","unstructured":"Cowan AC, Clemens KK, Sontrop JM, Dixon SN, Killin L et al (2023) Magnesium and fracture risk in the general population and patients receiving dialysis: a narrative review. Can J Kidney Health Dis 10:20543581231154183. https:\/\/doi.org\/10.1177\/20543581231154183","journal-title":"Can J Kidney Health Dis"},{"key":"1682_CR58","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/asn.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Dehmel B, Goodman WG, Dr\u00fceke TB, Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators (2015) Effects of Cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol 26:1466\u20131475. https:\/\/doi.org\/10.1681\/asn.2014040414","journal-title":"J Am Soc Nephrol"},{"key":"1682_CR59","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00774-024-01500-y","volume":"42","author":"T Wakamatsu","year":"2024","unstructured":"Wakamatsu T, Yamamoto S, Matsuo K, Taniguchi M, Hamano T, Fukagawa M, Kazama JJ (2024) Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials. J Bone Miner Metab 42:316\u2013325. https:\/\/doi.org\/10.1007\/s00774-024-01500-y","journal-title":"J Bone Miner Metab"},{"key":"1682_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s40620-024-02119-y","volume":"38","author":"AL Negri","year":"2025","unstructured":"Negri AL, Bover J, Vervloet M, Cozzolino M (2025) New calcimimetics for secondary hyperparathyroidism in CKD G5D: do they offer advantages? (in eng). J Nephrol 38:415\u2013421. https:\/\/doi.org\/10.1007\/s40620-024-02119-y","journal-title":"J Nephrol"},{"key":"1682_CR61","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.ajkd.2020.02.439","volume":"76","author":"SC Palmer","year":"2020","unstructured":"Palmer SC, Mavridis D, Johnson DW, Tonelli M, Ruospo M, Strippoli GFM (2020) Comparative effectiveness of calcimimetic agents for secondary hyperparathyroidism in adults: a systematic review and network meta-analysis. Am J Kidney Dis 76:321\u2013330. https:\/\/doi.org\/10.1053\/j.ajkd.2020.02.439","journal-title":"Am J Kidney Dis"},{"key":"1682_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111378","volume":"150","author":"Y Gao","year":"2021","unstructured":"Gao Y, Chai F (2021) Risk of non-vertebral fractures in men with type 2 diabetes: a systematic review and meta-analysis of cohort studies. Exp Gerontol 150:111378. https:\/\/doi.org\/10.1016\/j.exger.2021.111378","journal-title":"Exp Gerontol"},{"key":"1682_CR63","doi-asserted-by":"publisher","first-page":"E1918","DOI":"10.1210\/jc.2012-1968","volume":"97","author":"EM Stein","year":"2012","unstructured":"Stein EM, Liu XS, Nickolas TL, Cohen A, McMahon DJ, Zhou B, Zhang C, Kamanda-Kosseh M, Cosman F, Nieves J, Guo XE, Shane E (2012) Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab 97:E1918-1926. https:\/\/doi.org\/10.1210\/jc.2012-1968","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-025-01682-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01682-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:28:05Z","timestamp":1784345285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-025-01682-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1682"],"URL":"https:\/\/doi.org\/10.1007\/s00774-025-01682-z","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TS received lecture fees from Astra Zeneca, Astellas Pharma, Novartis Pharm, Otsuka, Viatris, Mochida Pharmaceutical, Kyowa Kirin, and Kaneka Medix. MM reported receiving lecture fees from Kyowa Kirin, Sanwa Kagaku Kenkyusho, Kissei Pharmaceutical, and Fuso Pharmaceutical Industries. KY received lecture fees from Novartis Pharm and Kyowa Kirin. TK reported receiving lecture fees from Terumo Corporation, Novartis Pharm, and Kissei Pharmaceutical. NK received lecture fees from Kyowa Kirin, Torii Pharmaceutical, and Sanwa Kagaku Kenkyusho. EI reported receiving lecture fees from Eisai Co., Ltd., Bristol-Myers Squibb, and Chugai Pharmaceutical, and a consulting fee from BiPSEE Inc. HO reported receiving lecture fees from Astra Zeneca, Kissei Pharmaceutical, Kyowa Kirin, and Ono Pharmaceutical. FK reported receiving lecture fees from Kyowa Kirin, Sanwa Kagaku Kenkyusho, Ono Pharmaceutical, and participated in the advisory board of Kyowa Kirin. HH reported receiving consulting fees from Astellas Pharma, Kyowa Kirin, Torii Pharmaceutical, Bayer Yakuhin, and Mitsubishi Tanabe Pharma, and lecture fees from Astellas Pharma, Chugai Pharmaceutical, Kyowa Kirin, Torii Pharmaceutical, Bayer Yakuhin, Kissei Pharmaceutical, and Mitsubishi Tanabe Pharma. No other disclosures are reported.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective observational study was approved by the ethics committee of Showa Medical University Hospital (number: 2023-160-A) and was conducted according to the Declaration of Helsinki. The requirement for written informed consent was waived by the committee. Study information was publicly disclosed and patients were given an opportunity to opt\u2011out. The patients\u2019 data were accessed through the hospital\u2019s electronic medical record system between December 2023 and April 2024. During this data collection period, the authors had access to information that could identify individual patients. These data were de-identified and analysed anonymously.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}